Multiple Sclerosis Relapse Rates and Healthcare Costs with Generic Glatiramer Acetate: A Retrospective Claims Analysis of US Health Plan Data

被引：0
|
作者：
Kantor, Daniel [1 ]
Grabner, Michael [2 ]
Zhang, Xian [2 ]
Balu, Sanjeev [3 ]
Hall, Steven [3 ]
机构：
[1] Florida Atlantic Univ, Boca Raton, FL 33431 USA
[2] HealthCore Inc, Wilmington, DE USA
[3] Sandoz Inc, Princeton, NJ USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P129
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [31] Development of an Algorithm to Identify Multiple Sclerosis (MS) Disease Severity Based on Healthcare Costs in a US Administrative Claims Database
    Nicholas, Jacqueline
    Ontaneda, Daniel
    Carraro, Matthew
    Wu, Ning
    Jhaveri, Mehul
    Yang, Kun
    Jones, Daniel
    Livingston, Terrie
    NEUROLOGY, 2017, 88
  • [32] ANALYSIS OF 'REVOLVING DOOR' PATIENTS IN OPIOID DEPENDENT PATIENTS: THE IMPACT OF TREATMENT DISCONTINUATION ON RELAPSE RATES AND HEALTH CARE COSTS IN US PUBLIC HEALTH INSURANCE CLAIMS
    Clay, E.
    Zah, V
    Kharitonova, E.
    Ruby, J.
    Aballea, S.
    Khemiri, A.
    VALUE IN HEALTH, 2014, 17 (07) : A456 - A456
  • [33] Rates of pregnancy among women with multiple sclerosis over time by age, region, and payer type: a US retrospective claims database analysis
    Houtchens, M. K.
    Edwards, N. C.
    Stern, K.
    Phillips, A. L.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 431 - 432
  • [34] Costs and Outcomes of Clostridioides difficile Infections in Germany: A Retrospective Health Claims Data Analysis
    Schley, Katharina
    Heinrich, Kirstin
    Moisi, Jennifer C.
    Haeckl, Dennis
    Obermueller, Dominik
    Brestrich, Gordon
    von Eiff, Christof
    Weinke, Thomas
    INFECTIOUS DISEASES AND THERAPY, 2025, 14 (01) : 91 - 104
  • [35] MAIN DRIVERS OF DIRECT HEALTHCARE COSTS FOR OSTEOARTHRITIS IN THE US: A RETROSPECTIVE PRIVATE INSURANCE CLAIMS ANALYSIS THROUGH 2014
    Tatovic, S.
    Sikora, A.
    Imro, M.
    Pelivanovic, J.
    Vukicevic, D.
    Zah, V
    VALUE IN HEALTH, 2018, 21 : S194 - S195
  • [36] HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH DALFAMPRIDINE EXTENDED RELEASE IN MULTIPLE SCLEROSIS: A RETROSPECTIVE CLAIMS DATABASE ANALYSIS
    Krieger, S.
    Palli, S. R.
    Grabner, M.
    Elder, J.
    Aupperle, P.
    Guo, A.
    VALUE IN HEALTH, 2015, 18 (03) : A290 - A290
  • [37] Comparison of Multiple Sclerosis (MS) Relapses and Total Medical Costs for Users of Glatiramer Acetate and Beta Interferons: Two-Year Analysis of a US Managed Care Database
    Johnson, Kenneth P.
    NEUROLOGY, 2009, 72 (11) : A236 - A236
  • [38] Characteristics, treatment patterns, health care resource utilization and costs in patients with bullous pemphigoid: A retrospective analysis of US health insurance claims data
    Stirnadel-Farrant, Heide A.
    Xu, Xiao
    Kwiatek, Justin
    Jain, Priya
    Meyers, Juliana
    Candrilli, Sean
    Mines, Daniel
    Datto, Catherine J.
    JAAD INTERNATIONAL, 2023, 13 : 117 - 125
  • [39] Retrospective claims data analysis of ASCT characteristics and costs for working-age, multiple myeloma patients in the US, 2017-2019
    Chi, Whanhui
    Song, Juhyeon
    Varisco, Tyler J.
    LEUKEMIA RESEARCH REPORTS, 2025, 23
  • [40] Prevalence of comorbidities in patients with and without multiple sclerosis by age and sex: a US retrospective claims database analysis
    Kresa-Reahl, K.
    Edwards, N. C.
    Phillips, A. L.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 488 - 488
12345